AMD vs CTMX · P/E 157, rev $11.54B vs rev $138.1M
Advanced Micro Devices Inc (AMD) versus CytomX Therapeutics Inc (CTMX) — a side-by-side from cached financials, not a winner call.
Advanced Micro Devices Inc (AMD) is a semiconductors company listed on US. It is led by Lisa Su.
CytomX Therapeutics Inc (CTMX) is a biotechnology company listed on US.
Latest reported AMD revenue for 2026-06-27 was $11.54B. Net income was $2.30B. Revenue was up 12.5% from 2026-03-28 to 2026-06-27. AMD currently screens at market cap $760.48B and trailing P/E 156.5.
Latest reported CTMX revenue for 2024-12-31 was $138.1M. Net income was $31.9M. Revenue was up 36.4% from 2023-12-31 to 2024-12-31. CTMX currently screens at market cap $653.1M.
AMD currently screens at market cap $760.48B and trailing P/E 156.5. CTMX currently screens at market cap $653.1M.
Not investment advice. Open the AMD and CTMX stock pages for the full models.
Not investment advice.